3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
20
Lymphoma, Non-Hodgkin
20
Leukemia, Myeloid, Acute
11
Hodgkin Disease
8
Precursor Cell Lymphoblastic Leukemia-Lymphoma
7
Myelodysplastic Syndromes
6
Leukemia, Lymphocytic, Chronic, B-Cell
6
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
5
Lymphoma, Mantle-Cell
3
Lymphoma, Follicular
3
Gliosarcoma
3
Glioblastoma
3
Sezary Syndrome
2
Mycosis Fungoides
2
Lymphoma, T-Cell, Cutaneous
2
Lymphoma, Large-Cell, Immunoblastic
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, B-Cell, Marginal Zone
2
Lymphoma
2
Leukemia, Hairy Cell
2
Leukemia
2
Hematologic Neoplasms
2
Glioma
2
Burkitt Lymphoma
2
Warts
1
Waldenstrom Macroglobulinemia
1
Sarcoma, Myeloid
1
Recurrence
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Pinealoma
1
Interventions
Temozolomide
53
Bevacizumab
45
Radiotherapy
28
Radiosurgery
21
Carboplatin
14
Erlotinib Hydrochloride
11
Radiation
10
pembrolizumab
9
Magnetic Resonance Spectroscopy
9
Etoposide
9
Vorinostat
8
Trastuzumab
8
Irinotecan
8
Sunitinib
7
Sorafenib
7
Radiotherapy, Intensity-Modulated
7
Lomustine
7
Lapatinib
7
Capecitabine
7
dabrafenib
6
Ipilimumab
6
Imatinib Mesylate
6
Cyclophosphamide
6
Sirolimus
5
Hydroxyurea
5
Everolimus
5
Bortezomib
5
temsirolimus
4
cabozantinib
4
binimetinib
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Brain Neoplasms
×
plerixafor
×
Clear all
No trials found.